Pennsylvania Requires Coverage for Cancer Biomarker Testing

Effective January 1, 2025, Pennsylvania requires all state-regulates plans, including Medicaid, to cover biomarker testing under Act 39, reports Philly Voice. Biomarker testing is used to determine the unique makeup of a person’s cancer, which doctors can use to provide tailored care that includes the most effective treatments – sometimes with reduced side effects. Note: state-regulated insurance does not include the majority of employer-sponsored insurance plans.